SlideShare une entreprise Scribd logo
1  sur  12
Abbott
Dr. Wallace C. Abbott
1888.
Begins manufacturing dosimetric granules
1894
Dr. Abbott acquires and becomes editor of The Alkaloidal Clinic
1900
Officially incorporated as the Abbott Alkaloidal Company
1906
To reach more physicians, Dr. Abbott establishes the
company’s sales force
History
• 1900 Modest Origin
• 1910 Expanded to
oNew York (US)
oSeattle (US)
oSan Fransico (US)
oToronto (Canada)
• 1915 changed name Abbott Laboratories
• 1929 about 120 facilities world wide
• Major player
Innovator Products
• Chlorazene 1916
• Butyn 1923
• Nembutal 1930
• Pantothal 1936
• Halazone 1942
• Tridione
• Surbex 1945
• Disposable I.V. Set
• Aminosol 1947
• Selsun Susp. 1951
• Erythrocin 1952
• Hytrin 1987
Acquisitions...
Year Acquisition Price Strategic Fit
2001 Knoll (a unit of BASF) $6.9B (Cash) Acquired the rights to
Humira
2004 Therasense $1.1B (Cash Acquired products for
diabetes treatment
2005 Guidant’s vascular
unit
$5.5B (Cash) Acquired several vascular
products
2006 Kos Pharmaceutical $3.7B (Cash) Acquired cholesterol
treatments
2009 Advanced Medical
Optics
$2.8B (Cash) Acquired #1 maker of LASIK
surgical devices
2009 Solvay’s drug unit $6.6B (Cash) Expanded pharmaceutical
portfolio
2010 Piramel Healthcare $3.8B (Cash) Expanded pharmaceutical
portfolio abroad
Business in 2011
• Record revenues of 38.9 Billions $
• 59 % of income came from outside US
Abbott Johnson &
Johonson
Pfizer Merk & co. Eli lilly &
Co.
0.00%
5.00%
10.00%
15.00%
20.00%
25.00%
30.00%
35.00%
Net Profit
Margin
ROE
Drug development cost in $
0
200
400
600
800
1000
1200
1400
1975 1987 2001 2006
Abbott
Abbott
• Oct 2011 Abbott plans to separate in two
companies
Abbott
Laboratories
Abbot Abb Vie
Idea of Global Citizenship
•Supporting patient and consumers
oEducating Patient and professionals
oEnsuring Manufacturing Quality
oResponsible sales and marketing
practices
•Safeguarding Environment
o Economic
oEnvironmental
oSocial Wellbeing
Scientific
Expertise
Business
Acumen
Recourses
Employees
Future Steps
• Research & Development
o30 Compounds in development
o12 Nutritional products and Medical devices
• Partnering with
oAcademics
oGovernment
oPrivate companies
To Advance personalise medicine, to improve
healthcare technology and to fight neglected
tropical diseases
Products
Abbott

Contenu connexe

En vedette (8)

扶青團經營建議方針
扶青團經營建議方針扶青團經營建議方針
扶青團經營建議方針
 
Resum de la VIII Jornada de tabaquisme "On deixem de fumar"
Resum de la VIII Jornada de tabaquisme "On deixem de fumar"Resum de la VIII Jornada de tabaquisme "On deixem de fumar"
Resum de la VIII Jornada de tabaquisme "On deixem de fumar"
 
Ppt struc ture conditionaldfs
Ppt struc ture conditionaldfsPpt struc ture conditionaldfs
Ppt struc ture conditionaldfs
 
Customer Bulletin 0610 Polyisocyanurate vs. Cellular Glass Insulation
Customer Bulletin 0610 Polyisocyanurate vs. Cellular Glass InsulationCustomer Bulletin 0610 Polyisocyanurate vs. Cellular Glass Insulation
Customer Bulletin 0610 Polyisocyanurate vs. Cellular Glass Insulation
 
Companies bill 2012
Companies bill 2012Companies bill 2012
Companies bill 2012
 
321 unit 15 performance
321 unit 15 performance321 unit 15 performance
321 unit 15 performance
 
Adding a signature in outlook
Adding a signature in outlookAdding a signature in outlook
Adding a signature in outlook
 
Diffusion of the “spanish model” in latin america
Diffusion of the “spanish model”  in latin americaDiffusion of the “spanish model”  in latin america
Diffusion of the “spanish model” in latin america
 

Dernier

What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...
AnaBeatriz125525
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Dubai Multi Commodity Centre
 
NewBase 24 May 2024 Energy News issue - 1727 by Khaled Al Awadi_compresse...
NewBase   24 May  2024  Energy News issue - 1727 by Khaled Al Awadi_compresse...NewBase   24 May  2024  Energy News issue - 1727 by Khaled Al Awadi_compresse...
NewBase 24 May 2024 Energy News issue - 1727 by Khaled Al Awadi_compresse...
Khaled Al Awadi
 

Dernier (20)

Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical TrialsSalesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
Salesforce in Life Sciences - Best Ways to Leverage The CRM for Clinical Trials
 
India’s Recommended Women Surgeons to Watch in 2024.pdf
India’s Recommended Women Surgeons to Watch in 2024.pdfIndia’s Recommended Women Surgeons to Watch in 2024.pdf
India’s Recommended Women Surgeons to Watch in 2024.pdf
 
PitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for StartupsPitchBook’s Guide to VC Funding for Startups
PitchBook’s Guide to VC Funding for Startups
 
Stages of Startup Funding - An Explainer
Stages of Startup Funding - An ExplainerStages of Startup Funding - An Explainer
Stages of Startup Funding - An Explainer
 
Falcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small BusinessesFalcon Invoice Discounting Setup for Small Businesses
Falcon Invoice Discounting Setup for Small Businesses
 
Vendors of country report usefull datass
Vendors of country report usefull datassVendors of country report usefull datass
Vendors of country report usefull datass
 
FEXLE- Salesforce Field Service Lightning
FEXLE- Salesforce Field Service LightningFEXLE- Salesforce Field Service Lightning
FEXLE- Salesforce Field Service Lightning
 
Raising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE VenturesRaising Seed Capital by Steve Schlafman at RRE Ventures
Raising Seed Capital by Steve Schlafman at RRE Ventures
 
Cracking the Change Management Code Main New.pptx
Cracking the Change Management Code Main New.pptxCracking the Change Management Code Main New.pptx
Cracking the Change Management Code Main New.pptx
 
What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...What is social media.pdf Social media refers to digital platforms and applica...
What is social media.pdf Social media refers to digital platforms and applica...
 
IPTV Subscription UK: Your Guide to Choosing the Best Service
IPTV Subscription UK: Your Guide to Choosing the Best ServiceIPTV Subscription UK: Your Guide to Choosing the Best Service
IPTV Subscription UK: Your Guide to Choosing the Best Service
 
HR and Employment law update: May 2024.
HR and Employment law update:  May 2024.HR and Employment law update:  May 2024.
HR and Employment law update: May 2024.
 
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
8 Questions B2B Commercial Teams Can Ask To Help Product Discovery
 
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot ReportFuture of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
Future of Trade 2024 - Decoupled and Reconfigured - Snapshot Report
 
The Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdfThe Truth About Dinesh Bafna's Situation.pdf
The Truth About Dinesh Bafna's Situation.pdf
 
The Ultimate Guide to IPTV App Development Process_ Step-By-Step Instructions
The Ultimate Guide to IPTV App Development Process_ Step-By-Step InstructionsThe Ultimate Guide to IPTV App Development Process_ Step-By-Step Instructions
The Ultimate Guide to IPTV App Development Process_ Step-By-Step Instructions
 
The Inspiring Personality To Watch In 2024.pdf
The Inspiring Personality To Watch In 2024.pdfThe Inspiring Personality To Watch In 2024.pdf
The Inspiring Personality To Watch In 2024.pdf
 
NewBase 24 May 2024 Energy News issue - 1727 by Khaled Al Awadi_compresse...
NewBase   24 May  2024  Energy News issue - 1727 by Khaled Al Awadi_compresse...NewBase   24 May  2024  Energy News issue - 1727 by Khaled Al Awadi_compresse...
NewBase 24 May 2024 Energy News issue - 1727 by Khaled Al Awadi_compresse...
 
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlastUnlock Your TikTok Potential: Free TikTok Likes with InstBlast
Unlock Your TikTok Potential: Free TikTok Likes with InstBlast
 
12 Conversion Rate Optimization Strategies for Ecommerce Websites.pdf
12 Conversion Rate Optimization Strategies for Ecommerce Websites.pdf12 Conversion Rate Optimization Strategies for Ecommerce Websites.pdf
12 Conversion Rate Optimization Strategies for Ecommerce Websites.pdf
 

Abbott

  • 2. Dr. Wallace C. Abbott 1888. Begins manufacturing dosimetric granules 1894 Dr. Abbott acquires and becomes editor of The Alkaloidal Clinic 1900 Officially incorporated as the Abbott Alkaloidal Company 1906 To reach more physicians, Dr. Abbott establishes the company’s sales force
  • 3. History • 1900 Modest Origin • 1910 Expanded to oNew York (US) oSeattle (US) oSan Fransico (US) oToronto (Canada) • 1915 changed name Abbott Laboratories • 1929 about 120 facilities world wide • Major player
  • 4. Innovator Products • Chlorazene 1916 • Butyn 1923 • Nembutal 1930 • Pantothal 1936 • Halazone 1942 • Tridione • Surbex 1945 • Disposable I.V. Set • Aminosol 1947 • Selsun Susp. 1951 • Erythrocin 1952 • Hytrin 1987
  • 5. Acquisitions... Year Acquisition Price Strategic Fit 2001 Knoll (a unit of BASF) $6.9B (Cash) Acquired the rights to Humira 2004 Therasense $1.1B (Cash Acquired products for diabetes treatment 2005 Guidant’s vascular unit $5.5B (Cash) Acquired several vascular products 2006 Kos Pharmaceutical $3.7B (Cash) Acquired cholesterol treatments 2009 Advanced Medical Optics $2.8B (Cash) Acquired #1 maker of LASIK surgical devices 2009 Solvay’s drug unit $6.6B (Cash) Expanded pharmaceutical portfolio 2010 Piramel Healthcare $3.8B (Cash) Expanded pharmaceutical portfolio abroad
  • 6. Business in 2011 • Record revenues of 38.9 Billions $ • 59 % of income came from outside US Abbott Johnson & Johonson Pfizer Merk & co. Eli lilly & Co. 0.00% 5.00% 10.00% 15.00% 20.00% 25.00% 30.00% 35.00% Net Profit Margin ROE
  • 7. Drug development cost in $ 0 200 400 600 800 1000 1200 1400 1975 1987 2001 2006 Abbott Abbott
  • 8. • Oct 2011 Abbott plans to separate in two companies Abbott Laboratories Abbot Abb Vie
  • 9. Idea of Global Citizenship •Supporting patient and consumers oEducating Patient and professionals oEnsuring Manufacturing Quality oResponsible sales and marketing practices •Safeguarding Environment o Economic oEnvironmental oSocial Wellbeing Scientific Expertise Business Acumen Recourses Employees
  • 10. Future Steps • Research & Development o30 Compounds in development o12 Nutritional products and Medical devices • Partnering with oAcademics oGovernment oPrivate companies To Advance personalise medicine, to improve healthcare technology and to fight neglected tropical diseases